Fatigue in inflammatory bowel disease and its impact on daily activities
Philipp Schreiner,Jean-Benoît Rossel,Luc Biedermann,Philipp O Valko,Christian R Baumann,Thomas Greuter,Michael Scharl,Stephan R Vavricka,Valérie Pittet,Pascal Juillerat,Gerhard Rogler,Roland von Känel,Benjamin Misselwitz,Swiss IBD Cohort Study Group,Karim Abdelrahman,Gentiana Ademi,Patrick Aepli,Amman Thomas,Claudia Anderegg,Anca-Teodora Antonino,Eva Archanioti,Eviano Arrigoni,Nurullah Aslan,Diana Bakker de Jong,Bruno Balsiger,Polat Bastürk,Peter Bauerfeind,Andrea Becocci,José M Bengoa,Janek Binek,Mirjam Blattmann,Stephan Boehm,Tujana Boldanova,Jan Borovicka,Christian P Braegger,Stephan Brand,Francisco Bravo,Lukas Brügger,Simon Brunner,Patrick Bühr,Sabine Burk,Emanuel Burri,Matthias Butter,Sophie Buyse,Dahlia-Thao Cao,Ove Carstens,Dominique H Criblez,Fabrizia D'Angelo,Philippe Saussure,Lukas Degen,Joakim Delarive,Christopher Doerig,Barbara Dora,Susan Drerup,Carole Ducrey,Ali El-Wafa,Matthias Engelmann,Aude Erdmann-Voisin,Christian Felley,Markus Fliegner,Montserrat Fraga,Yannick Franc,Pascal Frei,Remus Frei,Michael Fried,Florian Froehlich,Raoul Ivano Furlano,Luca Garzoni,Martin Geyer,Marc Girardin,Delphine Golay,Ignaz Good,Ulrike Graf Bigler,Sébastien Godat,Beat Gysi,Johannes Haarer,Marcel Halama,Janine Haldemann,Pius Heer,Benjamin Heimgartner,Beat Helbling,Peter Hengstler,Denise Herzog,Cyrill Hess,Roxane Hessler,Klaas Heyland,Thomas Hinterleitner,Claudia Hirschi,Petr Hruz,Ioannis Kapoglou,Stephan Kayser,Céline Keller,Carolina Khalid-de Bakker,Christina Knellwolf,Christoph Knoblauch,Henrik Köhler,Rebekka Koller,Claudia Krieger,Patrizia Künzler,Rachel Kusche,Frank Serge Lehmann,Andrew Macpherson,Michel H Maillard,Michael Manz,Maude Martinho,Rémy Meier,Christa Meyenberger,Pamela Meyer,Pierre Michetti,Bernhard Morell,Patrick Mosler,Eleni Moschouri,Christian Mottet,Christoph Müller,Beat Müllhaupt,Leilla Musso,Michaela Neagu,Cristina Nichita,Jan Niess,Andreas Nydegger,Nicole Obialo,Cassandra Oropesa,Ulrich Peter,Daniel Peternac,Laetitia Marie Petit,Daniel Pohl,Marc Porzner,Claudia Preissler,Nadia Raschle,Ronald Rentsch,Sophie Restellini,Jean-Pierre Richterich,Sandra Riedmüller,Branislav Risti,Marc Alain Ritz,Nina Röhrich,René Roth,Vanessa Rueger,Markus Sagmeister,Gaby Saner,Riad Sarraj,Bernhard Sauter,Mikael Sawatzki,Sylvie Scharl,Martin Schelling,Susanne Schibli,Hugo Schlauri,Dominique Schluckebier,Daniela Schmid,Sybille Schmid,Jean-François Schnegg,Alain Schoepfer,Frank Seibold,Mariam Seirafi,Gian-Marco Semadeni,Arne Senning,Christiane Sokollik,Joachim Sommer,Johannes Spalinger,Holger Spangenberger,Philippe Stadler,Peter Staub,Dominic Staudenmann,Volker Stenz,Michael Steuerwald,Alex Straumann,Andreas Stulz,Michael Sulz,Michela Tempia-Caliera,Joël Thorens,Kaspar Truninger,Radu Tutuian,Patrick Urfer,Stephan Vavricka,Francesco Viani,Fabrizion Vinzens,Jürg Vögtlin,Roland Von Känel,Dominique Vouillamoz,Rachel Vulliamy,Marianne Vullièmoz,Paul Wiesel,Reiner Wiest,Stefanie Wöhrle,Bahtiyar Yilmaz,Samuel Zamora,Silvan Zander,Jonas Zeitz,Dorothee Zimmermann
DOI: https://doi.org/10.1111/apt.16145
Abstract:Background: Fatigue is a common symptom of chronic inflammation, including inflammatory bowel disease (IBD), resulting in significant impairment in quality of life. Aims: To identify the prevalence of fatigue in a large IBD cohort compared to the general population, address risk factors, and evaluate its impact on daily life. Methods: We evaluated 1208 IBD patients from the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) and 414 healthy controls. Significant fatigue was defined as a visual analogue scale (VAS-F, range 0-10) score ≥ 4. Secondary endpoints were severity of fatigue and its impact on daily activities with the Fatigue Severity Scale (FSS), with a score ≥ 4 indicative of fatigue. Demographic, IBD-related and psychiatric symptoms were assessed with a multivariate analysis of variance (MANOVA) model optimised for prediction of VAS-F (primary outcome) and FSS scores. Results: Overall, 672 IBD patients (55.6%) reported significant fatigue compared to 145 (35%) controls (OR 2.71; 95% CI 2.08-3.54; P < 0.001). In IBD, fatigue also significantly affected daily activities (FSS ≥ 4; 405 (33.5%) IBD patients vs 81 (19.6%) controls, P < 0.001). In the MANOVA model, fatigue levels were associated with female gender (coefficient 0.839; 0.556 - 1.123; P < 0.001), younger age at diagnosis (-0.031 per year; -0.042- -0.019; P < 0.001), shorter disease duration (-0.036 per year; -0.050- -0.022; P < 0.001), nocturnal diarrhoea (0.718; 0.295-1.141; P = 0.001), low educational level (P = 0.034) and symptoms of depression and anxiety. Conclusions: Fatigue is both more frequent and more severe in patients with IBD than in the general population.